… , are considered the main reasons for immunopathogenesis and inflammation in SARS-CoV-…
Consequent to different findings of the study in terms of CP therapy effect against COVID-19…

… with severe COVID-19, and immunosuppressive or immune enhancement therapy will …
current understanding of the immunopathogenesis of severe COVID-19, especially the role …

… and help identify new therapeutic strategies. Here, we review the pathophysiology of Covid-19
from the initial … In addition, we discuss the airway management of patients with Covid-19. …

… distress syndrome in fatal cases of COVID-19, several disease-modifying … therapies for
the treatment of COVID-19. In this Review, we discuss the immunological aspects of COVID-19 …

… There are not currently any specific therapy and/or vaccine for COVID-19 disease management…
immunopathogenesis in SARS-CoV-2 infection for improving of COVID-19 management. …

… associated with severe morbidity and mortality in COVID-19. Here a case is made for
considering IRAK4 or IRF5 inhibitors as potential therapies for the “cytokine storm” of COVID-19. …

… Coronavirus disease 2019 (COVID-19) is a viral disease caused by severe acute respiratory
syndrome coronavirus … The patient under tocilizumab therapy was followed with a rise in …

… IL-6 is highly overexpressed in severe COVID-19 patients that may suggest a plausible
therapeutic target to prevent the neurological consequences and brain damage seen in these …

… , and immunotherapy may have significant potential in the treatment of COVID-19. Based on
… COVID-19 and provide a summary from traditional and newer methods in curing COVID-19. …

… who have IPF, antifibrotic therapy may improve outcomes for COVID-19 patients with an … to
immunopathogenesis in COVID-19. Zhou et al. reported that a subset of CD4 + Th1 cells from …